ACP Smart Medicine® Updates
ACP Smart Medicine continually updates modules as new practice-changing guidelines are released. With over 70 updated modules in 2014 (Jan – March), ACP Smart Medicine provides quick access to the most current evidence-based medicine recommendations.
New treatments for Hepatitis C
New 2014 guidelines from the WHO and the AASLD/IDSA provide recommendations for the use of new antiviral medications (sofosbuvir and simeprevir) in addition to older drugs, with different recommendations based on genotype. ACP Smart Medicine provides links to the guidelines and summarizes the recommendations.
Which is the best risk assessment tool for managing anticoagulation in Atrial Fibrillation patients?
When considering anticoagulation for a patient with Atrial Fibrillation, ACP Smart Medicine helps you navigate multiple risk assessment tools. In the Atrial Fibrillation module, the Therapy section helps you make informed decision about anticoagulation, providing quick links to the recommended CHADS2-VASc tool and to the 2014 guideline from the ACCF/AHA/HRS.